Skip to content
OWKIN logo

OWKIN Alternatives & Competitors

12 companies similar to OWKIN — From token to patient impact

Companies similar to OWKIN

radiomics.bio logo — alternative to OWKIN

radiomics.bio

Radiomics, Deep Learning & Federated Learning for AI powered drug development trajectory a...

Aignostics logo — alternative to OWKIN

Aignostics

AI-powered tissue analysis, validated by pathologists

Enable Medicine logo — alternative to OWKIN

Enable Medicine

Spatial and multimodal insights powered by AI for your next therapeutic breakthrough.

Data4Cure, Inc. logo — alternative to OWKIN

Data4Cure, Inc.

Biomedical Intelligence. Turning data into cures.

Rival Readout

Competing with OWKIN? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout
Multiomic Health logo — alternative to OWKIN

Multiomic Health

AI-Enabled Precision Medicine for Cardiovascular Renal Metabolic (CRM) Disease

MDVerse logo — alternative to OWKIN
Intelligencia AI logo — alternative to OWKIN

Intelligencia AI

Applying machine learning in drug development

Mindpeak logo — alternative to OWKIN

Mindpeak

Our mission is to enable personalised cancer treatment through AI tissue diagnostics

BDD logo — alternative to OWKIN

BDD

Redefining Early Stage Development

Foresight Diagnostics (a Natera company) logo — alternative to OWKIN

Foresight Diagnostics (a Natera company)

Precision medicine company dedicated to improving the lives of cancer patients through imp...

Prokarium logo — alternative to OWKIN

Prokarium

LIVING CURES

Immunai logo — alternative to OWKIN

Immunai

Mapping the Immune System with AI to Improve Health

About OWKIN

OWKIN is a pioneering company at the intersection of AI and Biotechnology, founded in 2016 and headquartered in the United States. It positions itself as the first closed-loop AI generative biology firm, striving to set a new standard in biological reasoning. By developing the first BASI to revolutionize therapies, dia...

Services

AI Scientist development, Clinical trial decision support, Biopharmaceutical R&D insights, Precision diagnostic testing, Biopharma autonomous systems

Target Customers

Pharmaceutical companies, Biotech firms, Clinical researchers, Oncologists, Healthcare data scientists

Business keywords

AI-powered Drug Discovery, Generative Biology, Biological Reasoning Systems, Closed-loop AI Systems, Multimodal Data Analysis, Biopharma Partnerships, Federated Learning, Medical Diagnostics, Clinical Trial Acceleration, Oncology Treatment, Data Privacy In AI, Digital Pathology, Automated Lab Infrastructure, Healthcare Innovation

Business Model

B2B, SaaS, Platform

Revenue Model

Subscription, Licensing, Service Fee

Frequently Asked Questions

Companies similar to OWKIN include radiomics.bio, Aignostics, Enable Medicine, Data4Cure, Inc., Multiomic Health. They work in Biotechnology and Pharmaceutical and share OWKIN's focus on healthcare innovation, federated learning and digital pathology.
Bounce Watch lists 12 companies that share OWKIN's industries and are closest to it in business tags, services, target customers, business model and size.
OWKIN is a pioneering company at the intersection of AI and Biotechnology, founded in 2016 and headquartered in the United States. It positions itself as the first closed-loop AI generative biology firm, striving to set a new standard in biological reasoning. By developing the first BASI to revolutionize therapies, dia...

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around OWKIN: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Compiled from the BounceWatch company index. We last looked at OWKIN on 8 Nov 2026. The 12 companies listed here were last checked between 11 Mar 2026 and 8 Nov 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout